Shire (Pharmaceuticals) Overview

  • Year Founded
  • 1986

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 23,044

Employees

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $58.2B

Shire (Pharmaceuticals) General Information

Description

Manufacturer and marketer of specialty medicines intended to meet the needs of patients with rare diseases. The company specializes in developing products across core therapeutic areas including hematology, immunology, neuroscience, ophthalmic, internal medicine endocrine and hereditary angioedema.

Contact Information

Website
www.shire.com
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • Block 2 & 3 Miesian Plaza
  • 50-58 Baggot Street Lower
  • Dublin 2
  • Ireland
Primary Industry
Pharmaceuticals
Other Industries
Drug Discovery
Biotechnology
Vertical(s)
Corporate Office
  • Block 2 & 3 Miesian Plaza
  • 50-58 Baggot Street Lower
  • Dublin 2
  • Ireland

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Shire (Pharmaceuticals) Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Merger/Acquisition 08-Jan-2019 $58.2B Completed Generating Revenue
5. Debt - Acquisition 19-Sep-2016 Completed Generating Revenue
4. Merger/Acquisition 20-Oct-2014 Cancelled Generating Revenue
3. PIPE 20-Feb-2007 Completed Generating Revenue
2. IPO 15-Feb-1996 Completed Generating Revenue
1. Early Stage VC Completed Generating Revenue
To view Shire (Pharmaceuticals)’s complete valuation and funding history, request access »

Shire (Pharmaceuticals) Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Manufacturer and marketer of specialty medicines intended to meet the needs of patients with rare diseases. The company
Pharmaceuticals
Dublin, Ireland
23,044 As of 2017

Vienna, Austria
 

Stockholm, Sweden
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Shire (Pharmaceuticals) Competitors (62)

One of Shire (Pharmaceuticals)’s 62 competitors is CSL Behring (Biotechnology), a Corporation company based in Vienna, Austria.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
CSL Behring (Biotechnology) Corporation Vienna, Austria
Swedish Orphan Biovitrum Formerly VC-backed Stockholm, Sweden
BioCryst Pharmaceuticals Corporation Durham, NC
Merck & Co. Corporation Rahway, NJ
Biotest Formerly PE-Backed Dreieich, Germany
You’re viewing 5 of 62 competitors. Get the full list »

Shire (Pharmaceuticals) Patents

Shire (Pharmaceuticals) Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20250099541-A1 Compositions and methods for reducing oxidation of igf-1/igfbp Pending 19-Jan-2022
US-20230181527-A1 Apical sodium-dependent transporter inhibitor compositions Pending 26-Oct-2021
WO-2022197758-A1 Heteroaryl inhibitors of plasma kallikrein Inactive 17-Mar-2021
WO-2022197755-A1 Imidazopyridinyl inhibitors of plasma kallikrein Inactive 17-Mar-2021
US-20240226106-A1 Inhibitors of plasma kallikrein Pending 17-Mar-2021 A61K31/53
To view Shire (Pharmaceuticals)’s complete patent history, request access »

Shire (Pharmaceuticals) Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Shire (Pharmaceuticals) Former Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds
HealthCare Ventures Venture Capital Minority
Permira PE/Buyout Minority
SV Health Investors PE/Buyout Minority
To view Shire (Pharmaceuticals)’s complete investors history, request access »

Shire (Pharmaceuticals) Investments & Acquisitions (53)

Shire (Pharmaceuticals)’s most recent deal was a Merger/Acquisition with Sanaplasma. The deal was made on 06-Sep-2018.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Sanaplasma 06-Sep-2018 Merger/Acquisition Laboratory Services (Healthcare)
Certa Therapeutics 04-Jun-2018 Early Stage VC Drug Discovery
Rani Therapeutics 22-Dec-2017 Later Stage VC Drug Delivery
Radius Health 30-Jun-2017 Merger/Acquisition Pharmaceuticals
OncoResponse 23-Mar-2017 Early Stage VC Drug Discovery
You’re viewing 5 of 53 investments and acquisitions. Get the full list »

Shire (Pharmaceuticals) ESG

Risk Overview

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

Rank

Percentile

Pharmaceuticals

Industry

Rank

Percentile

Pharmaceuticals

Subindustry

Rank

Percentile

To view Shire (Pharmaceuticals)’s complete esg history, request access »

Shire (Pharmaceuticals) Affiliates

Subsidiaries (2)

Name Industry Location Year Founded
Shire Strategic Investment Group Wayne, PA 2011
Baxter International (Medical Equipment) Deerfield, IL

Shire (Pharmaceuticals) FAQs

  • When was Shire (Pharmaceuticals) founded?

    Shire (Pharmaceuticals) was founded in 1986.

  • Where is Shire (Pharmaceuticals) headquartered?

    Shire (Pharmaceuticals) is headquartered in Dublin, Ireland.

  • What is the size of Shire (Pharmaceuticals)?

    Shire (Pharmaceuticals) has 23,044 total employees.

  • What industry is Shire (Pharmaceuticals) in?

    Shire (Pharmaceuticals)’s primary industry is Pharmaceuticals.

  • Is Shire (Pharmaceuticals) a private or public company?

    Shire (Pharmaceuticals) is a Private company.

  • What is the current valuation of Shire (Pharmaceuticals)?

    The current valuation of Shire (Pharmaceuticals) is .

  • What is Shire (Pharmaceuticals)’s current revenue?

    The current revenue for Shire (Pharmaceuticals) is .

  • How much funding has Shire (Pharmaceuticals) raised over time?

    Shire (Pharmaceuticals) has raised $12.9B.

  • Who are Shire (Pharmaceuticals)’s investors?

    HealthCare Ventures, Permira, and SV Health Investors have invested in Shire (Pharmaceuticals).

  • Who are Shire (Pharmaceuticals)’s competitors?

    CSL Behring (Biotechnology), Swedish Orphan Biovitrum, BioCryst Pharmaceuticals, Merck & Co., and Biotest are some of the 62 competitors of Shire (Pharmaceuticals).

  • When was Shire (Pharmaceuticals) acquired?

    Shire (Pharmaceuticals) was acquired on 08-Jan-2019.

  • Who acquired Shire (Pharmaceuticals)?

    Shire (Pharmaceuticals) was acquired by Takeda Pharmaceutical.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process